New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches

This study describes the synthesis and biological activity of new imadazopyrazines as first-in-class CDK9 inhibitors. The inhibition of CDK9 is a well-established therapeutic target in cancer therapy. The new compounds were assessed using an in vitro kinase assay against CDK9. In this assay, compoun...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Aisha A. Alsfouk (Awdur), Hanan M. Alshibl (Awdur), Najla A. Altwaijry (Awdur), Ashwag Alanazi (Awdur), Omkulthom AlKamaly (Awdur), Ahlam Sultan (Awdur), Bshra A. Alsfouk (Awdur)
Fformat: Llyfr
Cyhoeddwyd: MDPI AG, 2023-07-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg